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ABSTRACT
The exosome-independent exoribonuclease DIS3L2
is mutated in Perlman syndrome. Here, we used ex-
tensive global transcriptomic and targeted biochem-
ical analyses to identify novel DIS3L2 substrates in
human cells. We show that DIS3L2 regulates pol
II transcripts, comprising selected canonical and
histone-coding mRNAs, and a novel FTL short RNA
from the ferritin mRNA 5′ UTR. Importantly, DIS3L2
contributes to surveillance of maturing snRNAs dur-
ing their cytoplasmic processing. Among pol III tran-
scripts, DIS3L2 particularly targets vault and Y RNAs
and an Alu-like element BC200 RNA, but not Alu re-
peats, which are removed by exosome-associated
DIS3. Using 3′ RACE-Seq, we demonstrate that
all novel DIS3L2 substrates are uridylated in vivo
by TUT4/TUT7 poly(U) polymerases. Uridylation-
dependent DIS3L2-mediated decay can be recapit-
ulated in vitro, thus reinforcing the tight cooperation
between DIS3L2 and TUTases. Together these results
indicate that catalytically inactive DIS3L2, character-
istic of Perlman syndrome, can lead to deregulation
of its target RNAs to disturb transcriptome home-
ostasis.
INTRODUCTION
The lifetimes of different RNA species vary significantly.
Although rRNAs, tRNAs and snRNA are very stable
molecules that are degraded only under particular condi-
tions such as stress (1), protein-coding transcripts (mRNAs)
have much shorter life spans. In eukaryotes, degradation
of RNA polymerase II transcripts, especially mRNAs, has
been extensively studied (reviewed in (2)). mRNA degra-
dation usually begins with shortening of the poly(A) tail
or endonucleolytic cleavage, followed by exonucleolytic de-
cay, which may proceed from either the 5′-end or the 3′-
end. Degradation from the 5′-end requires cap removal that
is mediated by the Xrn1 exoribonuclease, while the exo-
some complex governs degradation from the 3′-end. Re-
cent progress in high-throughput sequencing technologies
allowed the discovery of many non-coding RNAs (ncR-
NAs) and other variable RNAs that result from perva-
sive transcription and post-transcriptional misprocessing
events. However, little is known about the processing and
degradationmechanisms for these RNAs.More detailed in-
vestigation of this issue is needed, since ncRNAs have im-
portant influences on cell physiology (3,4).
The human genome encodes three processive 3′ to 5′ ex-
oribonucleases: DIS3, DIS3L and DIS3L2, each equipped
with aRNB catalytic domain (5). Through their N-terminal
PINdomains,DIS3 andDIS3L associate with either the nu-
clear or the cytoplasmic exosome complexes, respectively.
The nucleoli-enriched ribonuclease EXOSC10 (RRP6) is
also a part of the exosome complex (5–7). Meanwhile,
DIS3L2 lacks a PIN domain and is not known to be a
subunit of any macromolecular complex (8). DIS3L2 local-
izes to the cytoplasm (8,9) where it contributes to an evo-
lutionarily conserved, exosome-independent, cytoplasmic
RNA degradation pathway. Biochemical analyses showed
that DIS3L2 is a robust 3′ to 5′ exoribonuclease, capable of
degrading single- and double-stranded RNA substrates in
vitro (8). Recent structural analyses of S. pombe and mouse
DIS3L2 indicated that the wide channel leading to the cat-
alytic site allows this protein to degrade structured sub-
strates (10,11). siRNA-mediatedDIS3L2 depletion changes
the expression of manymRNAs, and increases the half-lives
of selected mRNAs and P-body amounts (8). Addition-
ally, DIS3L2 interacts with XRN1 suggesting these proteins
cooperate to degrade mRNAs from both termini, which
was shown to occur, at least partially, on polysomes (8).
S. pombe DIS3L2 also participates in mRNA metabolism
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and deletion of its gene is synthetically lethal with xrn1Δ,
since presumably both proteins act redundantly by degrad-
ing transcripts from either the 5′- or 3′-end (12).
Several lines of evidence point to a cooperative function
of DIS3L2 and the cytoplasmic terminal uridyltransferases
TUT4 and TUT7. DIS3L2 mediates mRNA decay during
apoptosis through degradation of uridylated intermediates
(13). Similarly, in S. pombe and in mouse embryonic stem
cells (ESC), DIS3L2 activity is preferentially enhanced by
3′-terminal uridine tails (11,12). DIS3L2 degrades uridy-
lated let-7 family pre-miRNAs and thus plays a role during
cell differentiation (14,15).
The possible association between abnormalities in
DIS3L2-mediated RNA metabolism and diseases suggests
that DIS3L2 also plays important roles in maintaining cell
homeostasis. Indeed, DIS3L2 mutations are involved in
Perlman syndrome (a rare overgrowth disorder) andWilms’
tumor (kidney cancer that typically occurs in children) (9).
DIS3L2 knockdown inHeLa cells results in aneuploidy, mi-
totic errors and deregulation ofmitotic control proteins and
their transcripts (9). Gene ontology (GO) analysis of high-
throughput RNA-Seq data showed that loss of DIS3L2 ex-
pression resulted in an increased abundance of transcripts
related to cell-cycle regulation, which partially explains the
elevated cell proliferation that occurs withDIS3L2 dysfunc-
tion (8). However, in order to understand how widespread
the role of DIS3L2-mediated RNA metabolism is, further
research is needed to identify additional DIS3L2 substrates
and to examine the role of terminal uridylation in their
degradation.
Here, we generated a comprehensive human cellular
model to study the role of DIS3L2 and performed global
transcriptomic analyses to investigate the genome-wide
consequences of DIS3L2 dysfunction. Our results revealed
novel DIS3L2 substrates, including selected mRNAs, vault
and Y RNAs, BC200 (an Alu-like element RNA), a novel
FTL short RNA from the ferritin mRNA 5′ UTR and
extended snRNAs, all of which are degraded by DIS3L2
in a uridylation-dependent manner. Our data suggest that
DIS3L2 dysfunctionmanifested through deregulation of its
substrate RNAs likely abolishes cell homeostasis and may
contribute to disease development.
MATERIALS AND METHODS
Human cell cultures and generation of stable cell lines
Human Flp-In T-REx 293 (HEK293) (Invitrogen) cells
were cultured in monolayers in Dulbecco’s modified Ea-
gle’s medium (DMEM, Gibco) supplemented with 10% fe-
tal bovine serum (FBS, Gibco) at 37◦C in a 5% CO2 incu-
bator.
The stable inducible HEK293 cell lines producing
DIS3L2 variants were obtained using ‘pAL 01’ and
‘pAL 02’ plasmid constructs and the Flp-In™ T-REx™
system according to the manufacturer’s guidelines. For
WT and mut variants of DIS3L plasmids, ‘pAL 03’ and
pAL 04’ were used, respectively. Plasmid generation is de-
scribed in detail in the Supplementary Data. Lipofec-
tamine2000 (Invitrogen) was used for transfection. Af-
ter establishment of stable cell lines, cells were cultured
as described above, but hygromycin B (Invitrogen, 100
g/ml) was added to the medium. To induce exogenous
gene expression, doxycycline (100 ng/ml) was added to the
medium. For experiment with inducer titration, the follow-
ing concentrations (ng/ml) of tetracycline were used: 0.2, 1,
2, 5, 10 and 100.Generation of the stable inducibleHEK293
cell lines producing different versions of DIS3 and RRP6
proteins as well as their culture and induction were de-
scribed previously (16).
RNA isolation
For RNA isolation, stable HEK293 cell lines producing
DIS3L2 and DIS3L variants were treated with doxycycline
(100 ng/ml) for 3 days before RNA was isolated using TRI
Reagent (Sigma-Aldrich) according to the manufacturer’s
guidelines.
cDNA synthesis and quantitative PCR (qPCR)
Total RNA (10 g) isolated from cells was treated with
4 U TURBO™ DNase (Ambion) in the presence of Ri-
boLock RNase Inhibitor (Thermo Fisher Scientific), ac-
cording to the manufacturer’s protocol. Phenol:chloroform
extraction was then performed and RNA was precipitated
with isopropanol. DNase-treated RNA (2 g) was used for
cDNA synthesis. Reverse transcription was carried out us-
ing a mixture of 50 pmol of an oligo(dT) primer, 250 ng
of random primers (Invitrogen) and SuperScript III Re-
verse Transcriptase (Invitrogen) according to the manufac-
turer’s guidelines, in a final volume of 20 l. Samples were
diluted 10-fold and mixed with 2.5 pmol of each qPCR
primer (see Supplementary Table S2 for sequences), 0.5 g
bovine serum albumin and Platinum® Quantitative PCR
SuperMix-UDG (Invitrogen), in a final volume of 10 l.
qPCRwas carried out in aRoche LightCycler® 480 system.
Negative controls (-RT) were included for each experiment
and showed an insignificant background. GAPDHmRNA
was used for normalization. Reaction specificity was con-
firmed by melting curve analysis. Analyses were conducted
in triplicate.
Northern blotting
Total RNA (10 g) was separated by electrophoresis in
a 1% agarose/0.4 M formaldehyde gel in NBC buffer (50
mM boric acid; 1 mM sodium acetate; 5 mM NaOH) and
transferred onto a Hybond-N+ nylon membrane (Amer-
sham Pharmacia Biotech) by overnight capillary transfer
in 20× SSC buffer (3 M NaCl; 0.3 M sodium citrate). The
RNA was then fixed on membranes by UV-crosslinking.
The blots were hybridized with probes in PerfectHyb Plus
hybridization buffer (Sigma-Aldrich) at 42◦C overnight.
Oligonucleotide probes (10 pmol/reaction) were labelled
with T4 PNK (NEB) and 1 l [ -32P]ATP (Hartmann An-
alytic; 3000 Ci/mmol) in a total volume of 10 l accord-
ing to themanufacturer’s guidelines (see Supplementary Ta-
ble S2 for sequences). After hybridization the membranes
were washed twice with 2× SSC, 0.1% SDS (40 min each)
at 42◦C. The membrane was exposed in a PhosphorIm-
ager cassette (Fuji Film) and analyzed by phosphorimag-
ing [FLA 7000 scanner (Fuji Film)]. Between successive
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hybridizations, the membranes were stripped using boiling
0.1% SDS followed by incubation at 65◦C.
For separation of shorter fragments, total RNA (10 g)
was fractionated in a polyacrylamide-urea denaturing gel
(6%, 0.5 or 1.0 mm thick) and transferred onto a Hybond-
N+ nylon transfer membrane by electroblotting (0.5× TBE
at 4◦C, for 90 min or 180 min, respectively). RNA was
then fixed onmembranes byUV-crosslinking and blots were
handled as described above.
RNA-Seq
For RNA-seq we used RNA samples treated with DNase
(performed as described above) and rRNA-depleted using a
Ribo-Zero Kit (Epicentre) according to the manufacturer’s
protocol. Strand-specific RNA libraries were prepared in
triplicate using a TruSeq RNA Sample Preparation Kit (Il-
lumina) as per the manufacturer’s protocol with several pre-
viously described modifications (16). The libraries were se-
quenced using an Illumina HiSeq sequencing platform to
an average number of 18.8 million reads per sample in the
75-nt paired-end mode.
Small-RNA-Seq
Following DNase treatment and ribodepletion of 10 g
total RNA that was performed as described above, RNA
molecules underwent TAP (Epicentre) treatment (5 U en-
zyme, 40 U RiboLock RNase Inhibitor) at 37◦C for 2 h.
After phenol:chloroform extraction and ethanol precipita-
tion, 30 pmol of pre-adenylated linker RA3 (Illumina) was
ligated using 200 U of T4 RNA Ligase 2 truncated (NEB,
M0242) in the presence of 12% PEG 8000 (NEB) and 20
U RiboLock RNase Inhibitor in T4 RNA Ligation buffer
(NEB) for 1 h at 25◦C in a final volume of 20 l, preceded
by denaturation at 70◦C for 2 min in the absence of enzyme.
In the next step, RTP primer (Illumina) was annealed by
incubating 30 pmol of the oligo with RNA according to
following scheme: 5 min at 75◦C, 30 min at 37◦C and 15
min at 25◦C. Afterward, 30 pmol of RA5 linker (Illumina)
was ligated with 10 U T4 RNA Ligase 1 (NEB, M0204)
in the presence of 1 mM ATP in T4 RNA Ligation buffer
(NEB) for 1 h at 25◦C, in a final volume of 30 l. One-
third of the ligation mixture was used for reverse transcrip-
tion, conducted with SuperScript III Reverse Transcriptase
in the presence of 20 URiboLock RNase Inhibitor, 0.5 mM
dNTPs and 0.01 M dithiothreitol (DTT) for 1 h at 42◦C,
in a final volume 20 l, following incubation at 42◦C for 2
min in the absence of enzyme. Finally, libraries were am-
plified in a PCR reaction with Phusion High-Fidelity DNA
Polymerase (Thermo Scientific) using 20 pmol of RP1 and
RPI X - primers (where X represents index number) (Illu-
mina) in a volume of 40 l. The following PCR profile was
used: initial denaturation at 98◦C for 30 s, then 10 cycles of
denaturation (98◦C, 10 s), annealing (60◦C, 30 s) and elon-
gation (72◦C, 30 s), followed by 5 min of final elongation
at 72◦C. Following PCR, libraries were purified with Mag-
netic Beads (Agencourt AMPure XP; Beckman Coulter),
according to the manufacturer’s guidelines, eluted in 12 l
RSB Buffer (Illumina) and separated in a 6% native poly-
acrylamide gel. Products ranging in size from 140 to 320 bp
were excised and retrieved from the acrylamide by a crush-
and-soak method and overnight incubation with elution
buffer (0.5 M ammonium acetate, 1 mM EDTA and 0.1%
SDS). Libraries were then precipitated and purified again
with Magnetic Beads. The quality of prepared libraries was
checked using the Bioanalyzer and High Sensitivity DNA
kit (Agilent Technologies).
RNA-Seq and small RNA-Seq analysis
RNA-Seq reads weremapped to a reference human genome
(hg38) using the STAR short read aligner with default set-
tings (version STAR 2.4.0b) to yield on average 83.1% and
79.4% uniquely mapped reads for WT and mutant samples,
respectively.
Reads from small RNA-Seq were aligned to the genome
using the STAR short read aligner with the outFilter-
ScoreMinOverLread and outFilterMatchNminOverLread
options set to 0.20. The mapping yielded on average 1.54
million and 1.21 million uniquely aligned reads in mutant
and WT samples, respectively. The quality control, read
processing and filtering, visualization of the results and
counting of reads for the GENECODE v22 comprehen-
sive annotation was performed using custom scripts and
elements of the RSeQC, BEDtools and SAMtools pack-
ages. Differential expression analyses were performed us-
ing the DESeq2 Bioconductor R package. GO analysis was
performed using DAVID. To calculate the score for GEN-
CODE gene type enrichment, the number of significantly
upregulated genes of a given type was divided by the total
number of expressed genes of the group (defined as at least
10 reads of coverage). The statistical significance of this en-
richment was estimated with Fisher’s exact test.
RACE-Seq
RNA for 3′-RACE-Seqwas treatedwithDNase (performed
as described above) and 2 g of DNase-treated RNA was
used to prepare libraries via the following steps: (i) RA3
linker ligation, (ii) RTP primer hybridization, (iii) reverse
transcription (carried out as described in the Small RNA-
Seq protocol), (iv) PCR amplification (different primers
compared to Small RNA-Seq; forward: gene specific primer
with RA5 sequence at the 5′ end (see Supplementary Ta-
ble S2 for sequences), reverse: RTP), (v) Clean-Up purifica-
tion (A&A Biotechnology, according to the manufacturer’s
protocol) and (vi) PCR amplification (different primers
than the previous PCR, forward: RP1, reverse: RPI X). For
PCR, 10 cycles of amplification were used except forU4atac
(RNU4atac) and U5 (RNU5A-1), when 30 cycles were per-
formed. After PCR, libraries were purified following elec-
trophoresis in a native, 6% polyacrylamide gel and then ad-
ditionally with Magnetic Beads (in the case of VTRNA1-
2 and RNY4 transcript) or with Magnetic Beads alone
(snRNA transcripts).
RACE-Seq analysis
Sequences were clipped off the adapters using cutadapt,
followed by R1 reads mapping to reference transcript se-
quences using bowtie2. R2 reads that had mates mapping
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to references were mapped to reference transcripts with
the soft-clipping option enabled (bowtie2 option––very-
sensitive-local). Transcript ends were determined based on
the mapping, whereas tails were analyzed based on soft-
clipped fragments of reads using in-house Perl and R
scripts. Soft-clipped fragments were treated as having a
polyU tail if they contained >80% uridines. For vtRNA1-
2 and Y4 transcripts, terminal uridines were included in
the soft-clipped part of the read. Due to high level of ma-
ture transcript reads in U1 and U11 samples, tails were an-
alyzed only for fragments mapped downstream of mature
transcript (positions 902 and 741 for U1 and U11, respec-
tively).
Altering iron levels
To change cellular iron levels, cells were treated with either
50 g/ml ferric ammonium citrate (FAC) or 100 M de-
feroxamine (DFO, both from Sigma) for 24 h, after which
RNA and proteins were isolated for northern blot and west-
ern blot experiments, respectively.
Analysis of FTL short uridylation status
Reads from the shortRNA library preparation aligning to
the FLT 3′ end were stripped of adapter sequences using
cutadapt, examined for the presence of untemplated se-
quences using the SamExtractClip tool of the JVarkit pack-
age, and the nucleotide composition was assessed with a
custom script.
TUT4 and TUT7 knockdown and overexpression
To achieve efficient knockdown of TUT4 andTUT7 expres-
sion in HEK293 cell lines producing different DIS3L2 vari-
ants, cells were seeded in six-well plates at 0.3× 106 cells per
well in a medium lacking antibiotics. On the next day (∼20
h post seeding), the cells in a single well were transfected
with 5 l RNAiMAX transfection reagent, combined with
either 30 pmol control siRNAs (medium GC or high GC
control stealth siRNA; Invitrogen ref. nos. 462000 and
462002) or a pool of siRNAs containing 15 pmol siRNAs
against either TUT4 or TUT7 (both Stealth siRNA from
Invitrogen ref. nos. HSS177328 and HSS149224) in 300 l
OPTI-MEM serum-free medium. Triplicates for each con-
dition were prepared. Sixteen hours post-transfection, the
mediumwas exchangedwith freshmedium containing peni-
cillin+streptomycin. Cells were harvested 72 h after trans-
fection. Around one-third of the cells were scraped with
medium, centrifuged and used for western blotting to verify
knockdown of protein expression. The remaining cells were
harvested with TRI Reagent for RNA retrieval.
For TUT4 andTUT7 overexpression, HEK293 cells were
seeded in six-well plates at 0.5 × 106 cells per well. On the
next day (∼20 h post seeding), cells from a single well were
transfected with 7 l Lipofectamine 2000 (Invitrogen) and
2.5 g pcDNA5/FRT/TO plasmid DNAs comprising a
cassette encodingN-terminally eGFP-tagged TUT4, TUT7
or their catalytically-inactive mutant versions, D1011A
and D1060A, respectively. Triplicate transfections for each
condition were performed. At 12 h post-transfection, the
medium was exchanged for DMEM+FBS containing 100
ng/ml tetracycline and penicillin+streptomycin. Transfec-
tion efficiency and eGFP-tagged protein expression were
tested by flow cytometry and western blotting (data not
shown). Cells were harvested 72 h post transfection with
TRI Reagent, and RNA was isolated as described above.
Production of recombinant DIS3L2
DIS3L2 CDS was cloned into the pET28 expression vec-
tor with a C-terminal 6xHis tag. The plasmids were trans-
formed intoBL21-RILEscherichia coli cells and plated onto
LB agar plates supplemented with kanamycin (50 g/ml)
and chloramphenicol (37.5 g/ml). A single colony was
used to start a 50 ml inoculum in LB + kanamycin and
chloramphenicol and the cells were allowed to grow for 12
h at 37◦C with constant rocking. The inoculum was then
used to start 1 l of culture in an autoinducing medium
(AIM-Formedium). The cells were allowed to proliferate for
48 h at 18◦C with constant rocking before they were har-
vested by centrifugation. The cell pellet was suspended in
150 ml Buffer 1 (20 mM Tris–HCl pH 8, 500 mM NaCl,
10 mM imidazole supplemented with protease inhibitors
and 50 g/ml lysozyme). The cells were lysed with Emul-
siflex for 15 min following the manufacturer’s guidelines.
The lysate was cleared by centrifugation at 37 000 rpm in
a Thermo FL37 8 × 100 rotor at 4◦C for 45 min. Recom-
binant DIS3L2 was bound to a 5 ml NiNTA FastFlow
column (Qiagen) using A¨kta Xpress, and the column was
washed with 20 column-volumes of Buffer 1 and 2 col-
umn volumes of Buffer 2 (20 mM Tris–HCl pH 8, 1 M
NaCl). DIS3L2 protein was eluted with Buffer 3 (20 mM
Tris–HCl pH 8, 500 mM NaCl, 300 mM imidazole). Col-
lected fractions were analysed by sodium dodecylsulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and those
containingDIS3L2were diluted to reach 100mMNaCl fol-
lowed by final purification on aRESOURCEQ column (GE
Healthcare). The purified protein was analysed by SDS-
PAGE, and the concentration was determined using a Nan-
odrop apparatus at 280 nm and the respective molar extinc-
tion coefficient. Samples were supplemented with glycerol
to 20%, frozen and stored at −80◦C.
TUT4 production
TUT4 was expressed in FreeStyle 293-F cells (Invitrogen).
The cells were cultured in 30 ml 5× FreeStyle 293 Expres-
sion Medium (Gibco) to a density of 1 × 106 cells/ml. The
cells were transfected using 90g linear PEI at 1g/l (Mw
= 25 000; Polysciences Inc.) and 30 g plasmid pZW GZ11
for eGFP-TEV-TUT4 expression (Supplementary Materi-
als and Methods). Following transfection, the cells were
cultured for 48 h at 37◦C, 5% CO2, with constant rock-
ing at 120 rpm. The cells were then centrifuged for 5 min
at 500 g and the resulting cell pellet was suspended in 5
ml buffer 1 (20 mM Tris–HCl pH 8, 500 mM NaCl 0.1%
Triton X-100 supplemented with 100 U viscolase (nucle-
ase; A&ABiotechnology) and protease inhibitors. Themix-
ture was rotated head-over-tail at 10◦C for 15 min and then
sonicated at 10◦C for 30 min using a Bioruptor sonicator
(Diagenode) operating in the heavy duty setting with 15 s
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pulses followed by 45 s pauses. The lysate was cleared by
centrifugation at 12 000 g at 4◦C for 20 min. The resulting
supernatant was bound to magnetic beads (CNBr-activated
SepFast Mag4F; Biotoolomics) coupled to an anti-GFP
nanobody (home-made) for 2 h at 10◦C with head-over-
tail rotation. The beads were then washed with 40 bed-
volumes buffer 1. TUT4 was released from the beads by
TEV protease digestion in 300 l buffer 1 supplemented
with 10 g TEV protease (home-made) for 12 h. The re-
leased and bead-retained proteins were analysed by SDS-
PAGE. Aliquots were supplemented with glycerol to 20%,
frozen and stored at −80◦C.
In vitro vault RNA and Y RNA degradation assays
DNA sequences corresponding to RNY4, VTRNA1-
1 and VTRNA1-2 were retrieved from a nr (non-
redundant) nucleotide database (respective accession num-
bers: NR 004393.1, NR 026703.1 and NR 026704.1) and
chemically synthesized with additional sequences from
the T7 RNA polymerase promoter (agatgtaatacgactcac-
tatagg) at the 5′-ends. RNY4, VTRNA1-1, VTRNA1-2 se-
quences and variants of the latter comprising 2, 4 and 6
Us were amplified by PCR, and the RNAs were produced
by standard in vitro transcription with a home-made T7
RNA polymerase. The transcripts were purified after elec-
trophoresis in 6% denaturing PAGE. Transcripts (2 g)
were dephosphorylated by FastAP (Thermo Fisher Sci-
entific) and purified by phenol:chloroform extraction and
precipitation. Dephosphorylated RNAs (10 pmol) were 5’-
labelled with [ -32P]ATP using PNK (NEB) in 0.5× NEB2
buffer and purified by 6% denaturing PAGE, elution in
300 mM NaOAc pH 5.3, 2 mM EDTA, 0.5 vol/vol phe-
nol:chloroform:isoamyl 25:24:1 at 10◦C overnight and pre-
cipitation. Two master mixes, one containing 50 nM ‘cold’
RNA and trace amounts of 32P-labelled RNA in 0.5×
NEB2 buffer with RNase inhibitor (RiboLock; Thermo
Fisher Scientific), and the other containing 50 nM recom-
binant DIS3L2 in 0.5× NEB2 buffer alone were adjusted
to 37◦C for 2 min and then rapidly combined in a 1-to-1
volumetric ratio to start a time-course in a total volume of
20 l. Time-point aliquots (3 l) at 3, 6, 9, 12, 22 and 40
min were withdrawn and rapidly quenched in 5 l ice-cold
formamide-RNA loading dye containing 10 mM ethylene-
diaminetetraacetic acid (EDTA). 0 and 40 min time point
aliquotswithout proteinswerewithdrawn either beforemix-
ing RNA (0 min) or after a 40 min incubation at 37◦Cwith-
out proteins. RNAs were separated by 18% (19:1) denatur-
ing PAGE in 40 cm × 40 cm gels at 600 V for 2h. The gels
were exposed in Phosphorimager cassettes for 40 min and
scanned using a Fuji PhosphorImager (FLA7000). Full-
length substrates and degradation products were quantified
using Multigauge software and quantification results were
plotted using GraphPad Prism software.
In experiments in which hTUT4 was added, 2 nM of
wild type or catalytically inactive mutant (D1011A) pro-
teins in 20 mM Tris–HCl pH 8, 0.5 M NaCl and 25% glyc-
erol were included in the reactions (added to the protein
master mix). The protein preparation or respective buffer
(control w/o protein) constituted 1/10th of the final reac-
tion volume. UTP (1 mM) was added to both master mixes
before combining them and commencing the time-course.
The presence of UTP slowed down the DIS3L2 degrada-
tion kinetics (data not shown) in a concentration dependent
manner, which accounts for the difference in the calculated
half-times of the vault RNA1-2 in degradation assays with-
out and with TUTs and UTP.
In vitro vault RNA and Y RNA uridylation assays
RNY4, VTRNA1-1 and VTRNA1-2 (50 nM) prepared
as described above were combined with 2 nM wild type
or catalytically inactive (D1011A) hTUT4 as described
for the degradation assays, but without DIS3L2. RNAs
were separated by 10% sequencing PAGE (20 cm × 50
cm gels) at 2100 V for 3 h 15 min, exposed to a Phos-
phorimager screen, scanned and quantified as described
above. Control reactions were carried out with 50 nM 5′-
FAM-labelled 44-mer RNA (CGACUGGAGCACGAG-
GACACUGACAUGGACUGAAGGAGUAGAAA). The
RNAswere separated by 6%denaturing PAGEand scanned
using a FLA-9000 fluorescence scanner (GE Healthcare).
Cell fractionation
Stable inducible human HEK293 cell lines were cultured in
100mmdishes and treated with doxycycline (100 ng/ml) for
3 days. To obtain RNAs from different cellular compart-
ments, cells were fractionated after induction using a pre-
viously described procedure (17) with slight modifications
(see Supplementary Materials and Methods).
4sU labelling
Stable inducible human HEK Flp-In T-REx cell lines pro-
ducing WT/mut versions of DIS3L2 were cultured in 100
mm dishes and treated with doxycycline (100 ng/ml) for 3
days. 4sU labelling was carried out as previously described
(18) with minor modifications (see Supplementary Materi-
als and Methods).
RESULTS
Global analysis of DIS3L2 substrates
For global analyses of DIS3L2 functions, we established
a human cellular model based on stable cell lines derived
from parental HEK293 Flp-In T-Rex cells expressing sh-
miRNAs to silence endogenous DIS3L2, and simultane-
ously producing sh-miRNA-insensitive versions of DIS3L2
that were either wild type (WT) or the catalytically-inactive
mutant D391N (mut) (8). We chose the D391N mutation
because mutations leading to inhibition of DIS3L2 ribonu-
clease activity were identified in patients with the Perlman
syndrome (9). Validation experiments showed efficient si-
lencing of endogenous DIS3L2 and potent production of
exogenous proteins (Supplementary Figure S1), which con-
firmed that the system was working properly.
To investigate DIS3L2 functions genome-wide, total
RNA samples were collected from model cell lines produc-
ing either WT or mut DIS3L2 three days after induction
with doxycycline. The RNA samples were rRNA-depleted
before preparation of strand-specific total RNA libraries
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according to the standard TruSeq (Illumina) protocol. The
samples were sequenced and mapped to an average depth
of 15.3 million uniquely aligning reads. Since DIS3L2 is
a cytoplasmic nuclease, there were no effects on spurious,
nascent transcription degradation, as visualized by the un-
altered fraction of the genome portion that was poorly cov-
ered (Figure 1A) and the majority of reads (on average
79.2%) that mapped to exons of known genes.
RNA-Seq data analysis summarized in aMAplot showed
differential gene expression between cells producing WT
and mut DIS3L2, which had global deregulation of mRNA
(Figure 1B). Differential expression analysis with a 1%
FDR cut-off revealed that there were 809 upregulated genes
and 764 downregulated genes in DIS3L2 mutant cells com-
pared to WT cells. However, the extent of deregulation
was moderate, with only 58 genes showing more than 2-
fold changes in expression (42 up- and 16-downregulated
in the DIS3L2 mutant). Selected mRNA targets were val-
idated by qPCR (Figure 1C, Supplementary Figure S2A).
In agreement with a previous report (8), mRNAs encod-
ing selected replication-dependent histones were also iden-
tified asDIS3L2 substrates (Figure 1D, Supplementary Fig-
ure S2B). Importantly, the effect was not related to general
changes in the cell cycle, which is known to have a huge im-
pact on the histone mRNA expression, as verified by flow
cytometry analysis (Supplementary Figure S2C), suggest-
ing that histone-coding mRNAs are direct DIS3L2 targets.
Furthermore Gene Ontology (GO) analysis of statistically
significant hits showed no deregulation of a specific path-
way, but rathermoderate deregulation of general homeosta-
sis processes. Clustered GO analysis of transcripts accumu-
lating in the presence of mutated DIS3L2 using DAVID in-
dicated that DIS3L2 substrates are involved in chromatin
assembly and nuclear organization, ribosome structure and
translation, mitotic cell cycle and the M-phase regulation
(Figure 1E).
Although most deregulated RNAs followed the size dis-
tribution characteristic of all expressed transcripts, among
the upregulated genes in DIS3L2 mut cells there was an
overrepresentation of transcripts shorter than 1kb, with a
clear peak at about 100 nt (Figure 1F). Similarly, the GEN-
CODE gene types representing snRNA were significantly
enriched (Figure 1G), even though standard TruSeq library
preparation favours RNA molecules longer than 200 nt,
and shorter transcripts are suboptimal for sequencing via
this protocol. Thus, to obtain information about potential
DIS3L2 RNA substrates with lengths between 20 and 220
nt, another RNA-Seq was carried out in parallel (see Mate-
rials and Methods).
For small RNA-Seq analysis, 4802 transcripts were as-
sembled de novo by Cufflinks (Figure 2A), which showed
that 3,941 did not belong to any GENCODE annotation
(Figure 2B). A custom transcript annotation was then pre-
pared by integrating the de novo assembled transcriptome
into the GENCODE annotated short RNAs. The expres-
sion changes in the DIS3L2 mutant were moderate, with
only 12 genes and 9 genes showing at least 1.5-fold up-
and down-regulation, respectively (Figure 2C). The top hits
accumulating with DIS3L2 dysfunction that had a FDR
threshold lower than 5% were vault RNAs, Y RNAs and
snRNAs.
Specific classes of non-codingRNA: vault RNAs andYRNAs
are DIS3L2 substrates
Analysis of the small RNA-Seq data showed that DIS3L2
dysfunction leads to a significant upregulation of certain
non-codingRNAs transcribed by polymerase III. As shown
in selected Genome Browser views, some vault RNAs
(vtRNA1-1, vtRNA1-2, vtRNA1-3) and, to a lesser extent,
Y RNAs (Y1, Y3 and Y4), were among the most promi-
nently upregulated (Figure 3A–C). These results were val-
idated by northern blot (Figure 3D, Supplementary Fig-
ure S4A). Curiously, we observed smearing of the RNAs
towards longer species in DIS3L2 mut cells (Figure 3D),
indicating that the elongated vault and Y RNAs are pref-
erential DIS3L2 substrates in vivo. To ensure that the ob-
served length increase is not due to changes in transcrip-
tion start sites, primer extension analysis for vtRNA1-
1 and Y4 transcripts was performed, which showed no
change in the 5′-end position (Supplementary Figure S3).
Given that uridylation often constitutes signal enhancing
DIS3L2-mediated decay (13–15), we hypothesized that the
observed smearing is a consequence of the addition of non-
templated uridines to the 3′-ends of transcripts. This hy-
pothesis was tested for both analyzed RNAs by RACE and
massive parallel sequencing on Illumina NextSeq (RACE-
Seq). Since vault1-2 and Y4 are polymerase III transcripts,
more than 30% ended in three and four or five uridines, re-
spectively. Importantly, the results showed an accumulation
of longer vtRNA1-2 and Y4 RNA with 3′ non-templated
nucleotide additions in cells expressing mutant DIS3L2 and
the nucleotides added to the 3′-end were almost exclusively
uridines (Figure 3E, Supplementary Table S1 and Supple-
mentary Figure S4B). For vtRNA1-2, nearly 48% and 19%
comprised non-templated 3′ uridines in mutant and wild
type cells, respectively (Supplementary Table S1). The po-
tential candidates that mediate ncRNAuridylation were cy-
toplasmic TUTases, especially TUT4 and TUT7, which are
known to uridylate another DIS3L2 substrate, let-7 pre-
miRNA (14,15,19–21). To investigate whether TUTases are
responsible for uridylation of vtRNAs and Y RNAs in
our experimental cell lines in vivo, TUT4 and TUT7 were
silenced with respective siRNAs and vtRNA1-2 and Y4
transcripts were then inspected by northern blot. Impor-
tantly, smears representing elongated vault and Y RNAs
disappeared uponTUTase knockdown (Figure 3F and Sup-
plementary Figure S5B). To test whether TUT4 or TUT7
overexpression impacts vaultRNA1-2 and Y4 abundance
in vivo, HEK293 cells were transfected with plasmids for
tetracycline-inducible overexpression of wild type or cat-
alytically inactive TUT4 or TUT7. Northern blot analysis
demonstrated that overexpression of wild type TUT7 and,
to a lesser extent, wild type TUT4 (but not mutant vari-
ants of both TUTases) led to a decrease in the amounts
of vtRNA1-2 (Figure 3G, Supplementary Figure S5C). A
similar, but less pronounced, effect was visible for Y4 tran-
scripts (Supplementary Figure S5D). These data indicated
that uridylation likely promotes DIS3L2-mediated degra-
dation of vault and Y RNAs.
To gain deeper insight into the kinetics of DIS3L2-
mediated vtRNA and Y RNA degradation and to better
assess how uridylation regulates this process, in vitro bio-
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Figure 1. Global analysis of DIS3L2 substrates. (A) RNA-Seq showed no significant difference between the genome fractions covered by RNA-Seq reads
to given depths in WT and mutant DIS3L2 expressing cells. Bars represent the standard deviation for three biological replicates. (B) MAplot of total RNA
sequencing results representing differential expression of DIS3L2WT compared to DIS3L2 mut. Statistically significant hits (FDR < 1%) are color-coded
red. Transcripts accumulating in the DIS3L2 mut have a positive value on the y-axis. (C andD) mRNAs are DIS3L2 substrates. Screenshots fromGenome
Browser showing genomic regions encoding CGA mRNA (C) or HIST1H2AK mRNA (D), with reads from deep sequencing for WT and mut DIS3L2.
Number denotes the normalized expression measured by RNA-Seq (left); validation of CGA mRNA (C) and HIST1H2AK mRNA (D) accumulation in
mut DIS3L2 by qPCR (bars represent the standard deviation for three biological replicates) and northern-blot (5S rRNA was used as an internal control),
respectively (right). (E) Clustered GO analysis of genes accumulating in the DIS3L2 mutant. (F) Exon size distribution in genes that were upregulated in
mutant DIS3L2 relative to all expressed genes is skewed towards a minor gene population with exons shorter than 1 kb and a maximum of approximately
150 nt. (G) Enrichment analysis of GENCODE transcript types among transcripts accumulating in DIS3L2 mutant cells compared to all expressed genes
reveals a significant overrepresentation of snRNA. Other classes of short and non-protein coding RNA molecules, including miRNA, miscRNA and
snoRNA, also showed moderate enrichment. Right, Fisher exact test P-value.
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Figure 2. Analysis of short (20-200 nt) RNADIS3L2 substrates. (A) Venn
diagram summarizing de novo annotation of transcripts in theDIS3L2mu-
tant and WT samples. (B) Histogram representing distribution of size an-
notations in Cufflinks de novo transcriptome assembly. Potentially novel
transcripts are shown in yellow. (C) MAplot of small RNA sequencing
results demonstrates differential expression in DIS3L2 WT compared to
DIS3L2 mutant. Statistically significant hits (FDR < 5%) are color-coded
red. Transcripts accumulating in the DIS3L2 mut have a positive value on
the y-axis.
chemical time-course assays were performed. In vitro tran-
scribed 5′ 32P-labelled vtRNA1-1, vtRNA1-2 or Y4 RNA
were combined in a 1:1 molar ratio with purified recombi-
nant DIS3L2. Each RNA served as a substrate for DIS3L2
degradation (Figure 4A), and DIS3L2 acted processively
to produce short oligonucleotide degradation products and
few longer degradation intermediates, which faded as time
progressed. Among these RNA substrates, Y4 was most
readily degraded by DIS3L2 (the half-life of full-length
RNA was ∼7 min), while vtRNA1-2 seemed less prone to
degradation (half-life 17 min) (Figure 4B). The degrada-
tion kinetics of vault and Y RNAs resembled those ob-
tained previously with duplex RNAs comprising few un-
paired 3′ nucleotides (8). This outcome is consistent with
the strong secondary structure of vault and Y RNAs and
a short stretch of 3–5 genomically-encoded unpaired Us
at the 3′-ends. Furthermore, a significant fraction (around
20%) of the full-length vault and Y RNAs was resistant to
DIS3L2-mediated degradation.
Since RACE-Seq analyses (Supplementary Table S1) re-
vealed the preferential addition of 1–2 uridines to the 3′-
ends of vtRNA1-2 and Y4 in vivo, we tested whether vault
and Y RNAs can be uridylated in vitro by purified TUT
proteins, and whether TUTs would add single U, oligo-
or poly-U tails. The tests were performed with vtRNA1-
1, vtRNA1-2 or Y4 and full-length wild type or catalyti-
cally inactive mutant (D1011A) TUT4 proteins that were
affinity-purified from human cells.We observed preferential
addition of 1–2 uridine residues to the 3′-end of either RNA
type by wild type TUT, but not the mutant variant (Figure
4C and D). At the final time-point of our assay (40 min),
those RNA substrates extended by 1–2 uridines constituted
∼70% of the total, while those extended by ≥3 uridines
constituted ∼15%. In contrast, by the final time-point a
single-stranded, generic, fluorescently-labelled RNA sub-
strate (FAM44mer) acquired 80 to 100+ uridines under sim-
ilar conditions (Figure 4E). This finding that a limited num-
ber of uridines can be added to the 3′ ends of vault and Y
RNAs was in agreement with in vivo data. The reason why
TUTases act more efficiently on a linear substrate than on a
structured one remains to be determined. We further asked
whether the low number of uridines added to the 3′-ends
of vtRNA1-2 would influence the kinetics and efficiency
DIS3L2-mediated degradation in vitro. To this end, we per-
formed time-course assays that combined vtRNA1-2 with
DIS3L2 and, optionally, with either wild type or catalyt-
ically inactive TUT4. Indeed, vtRNA1-2 was degraded by
DIS3L2 faster and significantly more effectively in the pres-
ence of wild type TUT relative to either the mutant TUT or
the absence of TUT (Figure 4F and G) as evidenced by the
∼16min half-life of full-length vtRNA1-2 in the presence of
wild type TUT and the ∼26 min half-life for the two con-
trols. The enhancement ofDIS3L2-mediated vtRNAdegra-
dation by uridine addition was also obvious with synthetic
RNA substrates that had different lengths of non-templated
U tails (see Supplementary Figure S6A,B and Supplemen-
tary Note).
Together these analyses demonstrate that vault and Y
RNA are degraded by DIS3L2 in an uridylation-dependent
manner.
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Figure 3. Vault RNAs and Y RNAs are DIS3L2 substrates after TUT4/TUT7 uridylation (A–C). Screenshot from Genome Browser showing genomic
region encoding vtRNA1-1 (A), vtRNA1-2 (B) and Y4 RNA (C), with reads from deep sequencing for WT and mut DIS3L2. Number denotes the
normalized expressionmeasured by RNA-Seq (left); (D) Validation of transcript accumulations shown in panels a-c in DIS3L2mut as assessed by northern
blot. 5S rRNA was used as an internal control. (E) RACE-Seq results showing that vtRNA1-2 transcripts bearing 3′ non-templated nucleotide additions
accumulated in cells expressing catalytically inactive DIS3L2. Since vtRNA1-2 is a polymerase III transcript, it has four uridines encoded in the genome
(left side of dashed line). The distribution of reads with the selected U-tail length is shown (bars represent frequency of reads with selected U-tail length
normalized to total read counts). (F) Northern blot analysis of vtRNA1-2 in WT and mut DIS3L2 cell lines after siRNA-mediated TUTase repression.
5S rRNA was used as an internal control. (G) Northern blot analysis of vtRNA1-2 RNA in HEK293 parental cell line after transfection with plasmids
for tetracycline-inducible overexpression of wild type or catalytically inactive TUT4 or TUT7. ‘+’ indicates tetracycline induction and ‘-’ represents no
induction. 5.8S rRNA was used as an internal control.
DIS3L2 is involved in the degradation of the Alu-homologue-
derived RNA BC200, but not other Alu-like elements
Another ncRNA that is transcribed by polymerase III and
accumulates in the presence of mutated DIS3L2 is BC200
(also known as BCYRN1), a 200 nt-long non-coding RNA
(lncRNA) (Figure 5A). BC200 is enriched in the brain and is
thought to repress translation of several mRNAs that have
strong secondary structures at the 5′-end (22). Both north-
ern blot and qPCR analyses confirmed that BC200 is in-
deed strongly upregulated in DIS3L2 mutant cells (Figure
5B and C).
BC200 is transcribed from anAlu-like element composed
of a monomeric Alu repeat and a non-repetitive domain
(23). To find out if it is a specific DIS3L2 substrate, or
whether it represents a wider spectrum of Alu-derived tran-
scripts, northern blot experiment was conducted with a
probe complementary to another transcriptionally active
Alu element - AluYa5 (24) (Figure 5D). There was no ac-
cumulation of AluYa5 in the presence of mutated DIS3L2
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Figure 4. DIS3L2 preferentially degrades TUTase-uridylated substrates in vitro. (A) A typical time-course experiment visualized by denaturing PAGE and
phosphorimaging. In vitro transcribed, 5′ radioactively labelled Y4, vtRNA1-2 and vtRNA1-1 were incubated with purified recombinant DIS3L2 protein.
Aliquots were withdrawn at the indicated time points and reactions were stopped rapidly. (B) Results of 6 independent time-course experiments were
quantified by Multi Gauge software, plotted and fit with a single exponential decay equation using Graph Pad Prism software. (C) In vitro transcribed, 5′
radioactively labelled vtRNA1-2was incubated in the presence of either wild type or catalytically inactive (D1011A) TUT4. Reactions were rapidly stopped,
separated by 10% sequencing PAGE and visualized by phosphorimaging. The ladder on the left indicates the number of uridines added to the 3′ end of the
RNA. (D) As in panel C with Y4 and vtRNA1-1 used as substrates in the presence of WT TUT4. (E) As in panels C and D but a 5′ fluorescently labelled
(FAM) 44 mer RNA oligonucleotide was the substrate. The RNAs were separated by 6% PAGE and fluorescent signals were visualized with a Typhoon
FLA-9000 imaging scanner (GE Healthcare). (F) Representative PAGE analysis of a combined extension-degradation time-course assay of vtRNA1-2 in
the presence of DIS3L2 and either wild-type or catalytically inactive mutant TUT4 or buffer (control w/o TUT). The assay was visualized as in panel A.
(G) Plot summarizing results of four independent extension-degradation time-course assays (as in panel F). The graph was generated as in panel B.
(Figure 5E), in agreement with RNA-Seq data, in which
we haven’t seen increased levels of any specific Alu ele-
ments. In contrast, DIS3 dysfunction led to strong upregu-
lation of AluYa5 (Figure 5E).Moreover, short RNA arising
from Alu repeats accumulated, which appeared to be a left
monomer with an Alu sequence, known as scAlu (small cy-
toplasmic Alu) (25) (Figure 5E; Supplementary Figure S7).
These results indicate that BC200 is a specific DIS3L2
substrate, while AluYa5 levels are controlled by DIS3.
A stem loop at the 5′-end of ferritin mRNA accumulates as a
short RNA species in DIS3L2 mutant cells (FTL short)
Small RNA-Seq data analysis revealed that the catalytic
mutation in DIS3L2 led to significant accumulation of a
previously unknown, ∼80 bp long transcript originating
from the 5′ UTR of ferritin (FTL) pre-mRNA (Figure 6A).
Interestingly, this transcript corresponds to the short con-
served stem-loop iron-responsive element (IRE) that regu-
lates ferritin mRNA translation. When iron concentrations
are low and ferritin-mediated iron storage is not needed,
specific RNA binding proteins bind the ferritin IRE to in-
hibit translation (26,27). The existence and accumulation
of such novel short RNA species in mutated DIS3L2 was
confirmed by northern blot (‘FTL short’ in Figure 6B),
which showed that full-length ferritin transcript levels did
not change upon DIS3L2 mutation (‘FTL’ in Figure 6B).
To test whether the short FTL transcript (FTL short)
functions in iron homeostasis, we treated parentalHEK293,
WT and mut cells with ferric ammonium citrate (FAC)
or deferoxamine (DFO) to respectively increase or de-
crease iron concentrations. After treatment, the amounts
of FTL short did not change with regard to the untreated
cells (Figure 6C, Supplementary Figure S8A). Simultane-
ously, the abundance of the FTL protein grew upon FAC-
treatment and dropped upon DFO-treatment, confirming
proper activity of these compounds (Supplementary Fig-
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Figure 5. BC200, an Alu-like element RNA, is a DIS3L2 substrate, while DIS3 degrades transcripts from Alu-repeats. (A) Screenshot from Genome
Browser showing the genomic region encoding BC200 RNA with reads from deep sequencing for WT and mut DIS3L2. Number denotes the normalized
expressionmeasured byRNA-Seq. (B) Validation of BC200RNA accumulation inDIS3L2mut by northern blot. 5S rRNAwas used as an internal control.
(C) Validation of BC200 accumulation in mut DIS3L2 by qPCR. Bars represent the standard deviation for three biological replicates. (D) Example of
transcripts arising from Alu repeats (AluYa5) accumulating in DIS3 mut, but not in EXOSC10, DIS3L or DIS3L2 mutants. Schematic representation
of the AluYa5 transcript. Northern blot probe binding sites are shown for AluY5 1 and AluY5 2. (E) Northern blot showing accumulation of AluYa5
transcripts in DIS3 mut cells, including scAlu (small cytoplasmic Alu) (produced from AluY5a left monomer). 5.8S rRNAwas used as an internal control.
ure S8B). Thus, under these conditions, we were not able
to demonstrate any role of the FTL short transcript in iron
homeostasis regulation. Further investigation would reveal
whether it has a biological function or is a transcription by-
product.
We next examined the uridylation status of FTL short,
and found from RNA-Seq data that 39.6% of reads map-
ping to the FTL short 3′-end with DIS3L2 WT had a non-
templated U, compared to 63.3% of reads in DIS3L2 mut
samples. Furthermore, in mutant DIS3L2 cells a fraction of
FTL short had stretches of>2 Us, which were absent in the
WT control. This outcome strongly suggested that DIS3L2
is involved in degradation of uridylated FTL short (Figure
6D).
In summary, we identified a novel DIS3L2 substrate that
is a short transcript of unknown function derived from the
5′-UTR of ferritin mRNA.
RNA surveillance of maturing snRNA by DIS3L2
DIS3L2 dysfunction led to the accumulation of transcripts
originating from small nuclear RNA (snRNA) loci, but
longer than mature snRNAs (‘extended snRNAs’). This
outcome suggests that DIS3L2 may be involved in snRNA
processing during their biogenesis and/or surveillance (Fig-
ure 7A). In a typical biogenesis pathway of snRNAs, pri-
mary transcripts from snRNA loci are capped and the inte-
grator complex is responsible for initial endonucleolytic 3′-
end processing (28) that produces shorter precursors for ex-
port to the cytoplasm (29,30), where they associate with sur-
vival motor neuron complex (SMN) (31) to coordinate fur-
ther processing of snRNAs and their re-import into the nu-
cleus. These steps includemodification of the 5′-end to form
the 2,2,7-trimethylguanosine cap (TMG) (32) and matura-
tion following 3′-end trimming that is mediated by an un-
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Figure 6. Identification of FTL short, a novel transcript from the 5′-UTR of ferritin mRNA. (A) Screenshot from Genome Browser showing genomic
region encoding FTL mRNA with RNA-Seq and small RNA-Seq reads (see Materials and Methods) for WT and mut DIS3L2 cells. Number denotes the
normalized expression measured by RNA-Seq. (B) Validation of FTL short by northern blot after 6% PAGE. The amount of full-length ferritin mRNA
remained constant, as shown by northern blot after electrophoresis in 1% agarose. 5S rRNA was used as an internal control for both cases. (C) FTL short
possibly does not function in iron metabolism. Parental HEK293 cells were treated for 24 h with substances that alter environmental iron levels: FAC
(ferric ammonium citrate) and DFO (deferoxamine). The amounts of FTL short and full-length ferritin transcript were then analysed by northern blot.
5S rRNA was used as an internal control in both cases. Dashed lines indicate degraded RNA samples that were excised (second biological replicate). (D)
RNA-Seq results showing that FTL short transcripts bearing 3′ non-templated nucleotide additions accumulated in cells expressing catalytically inactive
DIS3L2. The distribution of reads with the selected U-tail length is shown (bars represent frequency of 3′ end reads with selected U-tail length normalized
to the total number of reads maping to 3′ end).
known nuclease. The mature snRNAs function in nuclear
splicing.
To gain insight into how DIS3L2 could contribute to
snRNA metabolism, we conducted northern blot hybridi-
sations with probes complementary to selected snRNAs,
which were located beyond 3′ end of mature transcripts. We
confirmed that extended snRNAs accumulate in DIS3L2
mutant cells. These transcripts were visible as distinct bands
that migrated more slowly than mature snRNAs, which
was demonstrated for U5 (RNU5A-1) (Figure 7B) and sev-
eral other snRNA species (Supplementary Figure S9A–D).
These extended forms could constitute snRNA precursors
(pre-snRNAs), however their relative size is bigger than so
far identified canonical pre-snRNAs (33).
To assess possible roles of other 3′–5′ exonucleases in
snRNA metabolism, RNA samples isolated from model
cell lines analogous to those described herein for DIS3L2,
but corresponding to EXOSC10, DIS3 or DIS3L exosome
catalytic subunits, were analysed in parallel. While dys-
functional DIS3L and EXOSC10 had no effect on snR-
NAs, in cells producing a mutant variant of DIS3 we noted
an accumulation of distinct, longer snRNA transcripts of
variable lengths that are presumably ‘read-through’ snR-
NAs thatmissed integrator-mediated processing and extend
to the region downstream of the termination site. These
longer forms accumulated particularly when both DIS3
PIN and RNB domains were mutated, indicating that both
endo- and exoribonucleolytic activities of DIS3 contribute
to snRNA degradation (Figure 7B, Supplementary Figure
S9A–D).
Importantly, and in contrast to accumulation of elon-
gated snRNA species, northern blot hybridisations for ma-
ture snRNAmolecules revealed that inmost cases there was
no change in their levels upon DIS3L2 dysfunction, while a
slight increase was observed for DIS3 (Figure 7B, Supple-
mentary Figure S9A-D and Supplementary Figure S10A).
These results indicate that neither DIS3L2, norDIS3 are es-
sential for snRNAmaturation. DIS3 could however partici-
pate in the decay of mature snRNA. To show that the effects
of DIS3L2mutation are specific for snRNA, we performed
northern blot analysis for another small RNA: snoRNA,
the maturation of which was previously shown to depend
on nuclear EXOSC10 andDIS3 (16). The lack of changes in
pre- andmature snoRNA levels in cells expressing cytoplas-
mic DIS3L and DIS3L2 indicates that these proteins likely
do not participate in snoRNA maturation (shown on the
example of SNORD13, see Supplementary Figure S10B).
These results are in agreement with the nuclear localisation
of snoRNAs through their entire life cycle. To further anal-
yse the subcellular location of accumulating extended snR-
Nucleic Acids Research, 2016, Vol. 44, No. 21 10449
Figure 7. DIS3L2-mediated surveillance of maturing U5 snRNA. (A) Screenshot from Genome Browser showing genomic region encoding U5 snRNA
with deep sequencing reads for WT and mut DIS3L2. Number denotes the normalized expression measured by RNA-Seq. (B) Northern blot verification
of extended snRNAs (‘ext’) in model cell lines producing wild-type or mutated EXOSC10, DIS3, DIS3L or DIS3L2. The level of mature snRNAs was
also analyzed. 5S rRNA was used as an internal control. (C) Extended snRNAs accumulating in the presence of mutated DIS3 and DIS3L2 are present in
the cytoplasm and the nucleus. The localization of extended snRNAs in different cellular compartments was assessed by cell fractionation and northern
blot analysis (tot – total RNA, nuc – nuclear RNA, cyt – cytoplasmic RNA). Analysis of mature U5 snRNA localisation after cell fractionation was
also conducted. Control of cell fractionation is identical as in Supplementary Figure S7. (D) Accumulation of extended U5 snRNAs does not influence
production of mature snRNA species. 4-thiouridine (4sU) labelling was used to study the kinetics of mature snRNA production. RNA was collected after
labelling and terminating reactions at the indicated time points. RNA labelled with 4sUwas retrieved by biotinylation and separation on streptavidin beads.
(E) Extended U5 snRNA transcripts bearing 3′ non-templated nucleotide additions accumulate in cells expressing catalytically inactive DIS3L2 as shown
by RACE-Seq. The distribution of reads with selected U-tail lengths is shown (bars represent the frequency of reads with selected U-tail length normalized
to total read counts). (F) Uridylation enhances degradation of extended snRNAs. TUT4 and TUT7 were silenced in model cell lines using siRNA (lanes
TUTs) and the presence of extended snRNA transcripts was monitored by northern blot. 5S rRNA was used as an internal control.
NAs and read-through forms, we carried out cell fractiona-
tions and isolated RNAs from the nuclear and cytoplasmic
fractions that were then subjected to northern blotting with
probes specific to U5 (RNU5A-1) or U4atac (RNU4atac)
(Figure 7C, Supplementary Figure S11A). The blot showed
that extended snRNAs accumulated upon DIS3L2 muta-
tion and the read-through forms of snRNAs accumulated
upon DIS3 mutations, are both present in the nucleus and
the cytoplasm. The localization of the read-through forms
indicates their ability to leave the nucleus when mutated
DIS3 is present.
To resolve whether DIS3L2 is involved in snRNA
processing or quality control, we treated cells with 4-
thiouridine (4sU) to investigate the production of newly
synthesized snRNAs in a time-dependent manner and as-
sessed how mutated DIS3L2 and accompanying accumu-
lation of extended snRNAs influenced the kinetics of ma-
ture snRNA production. There was no visible difference
between WT and mut versions of DIS3L2 in the produc-
tion of both mature U5 snRNA and U1 snRNA 15 min
to 120 min after the 4sU pulse (Figure 7D; Supplementary
Figure S11B). This result suggests that accumulation of ex-
tended snRNA species in the presence of mutated DIS3L2
(Supplementary Figure S11C), does not influence produc-
tion of mature snRNA. This implies that extended snRNAs
accumulating upon DIS3L2 mutation are non-functional
(meaning that DIS3L2 is involved in surveillance rather
than processing). In the second scenario, extended snRNAs
may still represent functional snRNA precursors in a novel
snRNA biogenesis pathway, and they are processed by an
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as yet unknown nuclease(s) in place of DIS3L2 (when mu-
tated).
Given that in the case of previously described ncRNAs
degraded by DIS3L2, uridylation constituted signal en-
hancingDIS3L2-mediated decay, we usedRACE-Seq to ex-
amine whether the elongated U5 snRNA is uridylated in
cells producing WT or mut versions of DIS3L2 or DIS3.
DIS3L2 mut cells showed a marked increase in uridylated
U5 and several other extended snRNA species relative to
WT cells (Figure 7E, Supplementary Figure S11D–F). Im-
portantly, RACE-Seq data analysis revealed that, relative
to previously described transcripts from snRNA biogen-
esis pathways, in the presence of DIS3L2 mutations, the
accumulating transcripts were longer and extended up to
70 nt, while canonical snRNA precursors have relatively
short (5–10 nt) overhangs (33). It agrees well with sizes
observed in northern blot analyses and further confirms a
role for DIS3L2 in snRNA surveillance rather than pro-
cessing. Additionally, in agreement with northern blot data,
we observed that ‘read-through’ transcripts accumulating
in the presence of DIS3 mutations are longer than snRNA
species seen when DIS3L2 is mutated (Supplementary Fig-
ure S11G).
We next investigated the possible role of TUT4 andTUT7
in extended snRNAs degradation using DIS3L2 model cell
lines and simultaneous siRNA silencing of selected TU-
Tases followed by northern blot quantification of U5 ex-
tended snRNA.We observed a relativelymodest, but clearly
additive effect of the DIS3L2 catalytic mutation and TU-
Tase depletion (Figure 7F), which supports the hypothe-
sis that TUT4 and TUT7-mediated uridylation marks ex-
tended snRNAs for degradation by DIS3L2, and that the
3′-terminal uridylation promotes their degradation.
Taken together, DIS3L2 and TUTs cooperate in surveil-
lance and degradation of maturing snRNA transcripts
while DIS3 is involved in the decay of snRNA ‘read-
through’ transcripts and mature snRNA molecules.
DISCUSSION
Previous studies showed that the Perlman syndrome nucle-
aseDIS3L2 participates in the decay of selectedmRNAand
pre-miRNA. In this study, we identified novel physiological
substrates of DIS3L2 and showed that DIS3L2 dysfunction
disturbs transcriptome homeostasis.
snRNA surveillance by DIS3L2
The complicated process of snRNA biogenesis begins with
the production of transcripts with amonomethyl-guanosine
(m7GpppG) cap and transcription-linked cleavage by the in-
tegrator complex (28) to produce nuclear precursor forms.
These precursors are then transported to the cytoplasm,
where they assemble with SMN complexes (31) that coor-
dinate hypermethylation of the m7GpppG cap (32), exonu-
cleolytic trimming, and formation of snRNP particles. Fi-
nally, snRNPs are reimported to the nucleus, where they
undergo additional remodeling. However, the nuclease that
is involved in cytoplasmic processing of snRNAs remains
elusive. We showed that DIS3L2 dysfunction promotes the
accumulation of RNA species that are longer than ma-
ture snRNAs, but without a concomitant change in mature
snRNA levels. These transcripts are typically longer than
known cytoplasmic snRNA precursors - e.g. for U1 and
U4 snRNAs, the cytoplasmic pre-snRNAs are only several
nucleotides longer than the corresponding mature species
(34,35), whereas the transcripts accumulating uponDIS3L2
mutation are up to 50 nt or 70 nt longer for U1 and U5, re-
spectively. Thus, DIS3L2 likely governs a surveillance path-
way for misprocessed precursors, which is also supported
by the lack of change in snRNA production kinetics that
was visualized by pulse-labelling with 4sU. Nonetheless, be-
cause of its potential redundancy with other nucleases that
has been documented for other processing events, we can-
not completely exclude the possibility that DIS3L2 is also
involved in snRNA processing (36).
Besides the involvement of DIS3L2 in snRNA biology,
our data indicate that the DIS3L2 homologue DIS3 par-
ticipates in the decay of mature snRNA and also degrades
‘read-through’ snRNAs that extend downstream of the ter-
mination sites. Assuming that DIS3L2 has a quality control
but not processing function, and taking into account the
finding that DIS3L and EXOSC10 mutations do not influ-
ence either form of snRNA, then the nuclease involved in
cytoplasmic processing of pre-snRNAs remains to be dis-
covered. However, we did demonstrate that both DIS3 and
DIS3L2 play roles in the surveillance of maturing snRNA
molecules, with the former overseeing their nuclear bio-
genesis, and the latter removing unwanted extended forms
from the cytoplasm. This function is particularly important,
given that these elongated transcripts could enter the nor-
mal snRNA biogenesis pathway (based on their dual local-
ization), which could sequester the processing machinery
from canonical precursors.
DIS3L2 surveillance of short cytoplasmic RNA species
Here, we identified several short cytoplasmic RNA species
as novel DIS3L2 substrates. The unifying feature of these
RNAs is their strong secondary structure that is similar to
the previously described DIS3L2 substrate, let-7 miRNA
precursors (37). Importantly, given known functions of
most of these transcripts, their dysregulation may have sig-
nificant physiological consequences.
Vault RNAs are non-coding RNAs that constitute part
of large vault ribonucleoprotein particles that are associ-
ated with multidrug resistance (38,39). Moreover, vtRNA1-
1 overexpression was recently shown to protect cells from
apoptosis (40). Given that DIS3L2 knockdown exerted a
similar effect, inhibition of programmed cell death in cells
that are defective in DIS3L2 activity (13) could be mediated
at least in part through this particular vtRNA.
Y RNAs play a role in DNA replication, RNA process-
ing and quality control, and are other members of the non-
coding RNA repertoire that are targeted by DIS3L2 (41).
TheY3 isoform (Y3**) was recently implicated in proper 3′-
end processing of histone pre-mRNAs since Y3** depletion
leads to misprocessed histone mRNAs without a change
in their total abundance (42). In the presence of mutated
DIS3L2, Y3 levels increased, but we did not observe mis-
processed histone mRNAs (Supplementary Figure S2D),
only their accumulation.
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Both vault RNAs and Y RNAs are thought to be a
source of smaller RNAs, namely svRNAs (43) and Ys-
RNAs (44), respectively. The findings that YsRNAs were
upregulated in breast cancer patients, which would make
them potential prognostic biomarkers (45), and that upreg-
ulation of a specific svRNAs is widespread in Parkinson’s
disease, thus suggesting potentially novel therapeutic ap-
proaches (46), significantly enhanced the interest in these
small RNAs. In terms of DIS3L2, catalytic mutants could
lead to svRNA and YsRNA overproduction that in turn
abolishes cell homeostasis.
Our RNA-Seq data showed that another consequence of
DIS3L2 dysfunction is upregulation of BC200, which is an
ncRNA that is produced by polymerase III and is normally
expressed in primate brain (23). BC200 is produced from a
monomeric Alu repeat and was shown to inhibit translation
initiation and possibly contribute to synaptic plasticity (22),
although whether DIS3L2 is involved in this mechanism re-
mains to be determined. In particular, it would be interest-
ing to explore whether DIS3L2 plays tissue-specific roles in
the brain. This possibility is consistent with unpublished
data by Nowak (personal communication), which showed
that pre-miR-9, a miRNA precursor that is important for
neuronal differentiation, is degraded by DIS3L2. Addition-
ally, we show that DIS3, but not DIS3L2, contributes to re-
moval of transcripts derived from Alu repeats. Since these
repeats are present in the human genome in more than 1
million copies that together represent up to 10% of DNA
(47), controlling the levels of the transcripts that are derived
from them may be highly relevant for maintaining genome
stability.
DIS3L2 and histone mRNAs
A prominent class of DIS3L2 mRNA substrates are
replication-dependent histone mRNAs. Since these mR-
NAs are quickly degraded after replication and lack poly(A)
tails, a uniquemechanism exists to remove these transcripts.
A stem loop structure (SL) present in the 3′ UTR of his-
tone mRNAs interacts with the SLBP protein and Eri1 ex-
oribonuclease (48). To initiate degradation, SLBP recruits
TUT4 (ZCCHC11), which adds an oligo(U) tail to serve as
a signal for Lsm1 (49) that in turn triggers histone mRNA
degradation - either from the 5′- (byXRN1 after decapping)
or the 3′-end through activation of ERI1. This ERI1 activa-
tion involves consecutive rounds of degradation and TUT4-
mediated uridylation to remove the SL structure, leading
to subsequent degradation by the RNA exosome complex
(48,49). Since our data indicate that DIS3L2mutations lead
to accumulation of replication-dependent histone mRNAs,
DIS3L2 may represent an alternate pathway for the degra-
dation of these mRNAs. DIS3L2 is known to be present in
polysomes (8), which is in agreement with the fact that his-
tone mRNA degradation also occurs during ongoing trans-
lation (50). Conversely, participation of DIS3L2 in this pro-
cess was questioned by Slevin et al. (50), who showed that
there is no change in histone mRNA degradation upon
DIS3L2 silencing. However, these authors used a siRNA
approach to downregulateDIS3L2 expression, which is not
always sufficient, as was shown previously by our labora-
tory (5). Furthermore, even if DIS3L2 expression was si-
lenced efficiently, histone mRNAs might still be removed
by other pathways, suggesting the existence of functional
redundancy. Furthermore, DIS3L2 may only degrade spe-
cific replication-dependent histone mRNAs.
The role of uridylation in DIS3L2-mediated decay
Earlier studies (13–15) showed that uridylation constitutes
a signal that enhances DIS3L2 activity towards let-7 pre-
miRNA. Moreover, the role of uridylation in the decay of
replication-dependent histone mRNAs, which are known
to accumulate upon DIS3L2 mutation, has been well-
documented (49). Here we found that the newly identified
DIS3L2 substates - vault RNAs, Y RNAs, FTL short and
extended snRNAs are all uridylated.
Our biochemical experiments with in vitro transcribed
vtRNA1-2 let us unequivocally conclude that uridylation
enhances DIS3L2 activity towards this substrate. On the
other hand, in vivo studies suggest that it is not indispens-
able for degradation, because we do not observe accumula-
tion of VTRNA1-2 and RNY4 transcripts after downreg-
ulation of the enzymes responsible for uridine tail synthe-
sis (TUTases), which, however, can be due to residual TU-
Tase activity after inefficient silencing (this is especially im-
portant considering the fact that there is a functional re-
dundancy between TUTases, depending on the nature of
the substrate (21)). Furthermore, after overexpression of
wild-type DIS3L2 we still observe a fraction of vault RNAs
and Y RNAs without additional uridines, which points to
preferential degradation of uridylated substrates in vivo. A
structure of mouse DIS3L2 (11) shows a significant net-
work of interactions between the DIS3L2 entrance channel
and an artificial oligo(U) substrate that explains the role of
the oligo(U) tail in enhancing DIS3L2-mediated RNA de-
cay. Additionally, structural data suggest that the DIS3L2
channel is sufficiently wide to allow for processing of struc-
tured substates (11). This hypothesis is in concordance with
our in vitro data, which demonstrated that DIS3L2 de-
grades unmodified Y4 with preference over vtRNA1-2 that,
in constrast, showed enhanced uridylation relative to Y4 in
a RACE-Seq experiment. This result suggests that uridyla-
tion may be particularly important for substrates that are
otherwise poorly degraded by DIS3L2 unless they are ad-
ditionally modified at the 3′ terminus.
Given recent information concerning widespread uridy-
lation (51) and the broad spectrum of DIS3L2 substrates,
we not only demonstrate that oligouridylation plays a
prominent role in the decay of these newly discovered
DIS3L2 substrates, but we also expand DIS3L2 exori-
bonucleolytic activity functions from simply contributing to
mRNA decay to controlling the levels of cytoplasmic non-
coding RNAs.
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